Blood group ABO polymorphism inhibits SARS‐CoV‐2 infection and affects COVID‐19 progression.

Autor: Yamamoto, Fumiichiro1 (AUTHOR) fyamamoto@carrerasresearch.org, Yamamoto, Miyako1 (AUTHOR), Muñiz‐Diaz, Eduardo2 (AUTHOR)
Zdroj: Vox Sanguinis. Jan2021, Vol. 116 Issue 1, p15-17. 3p. 1 Diagram.
Databáze: Academic Search Ultimate